Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 May 2023 | Story Samkelo Fetile | Photo iFlair Photography
Modular Lecture Building
The Modular Lecture Building on the UFS’s Bloemfontein Campus.

The University of the Free State’s (UFS) Modular Lecture Building on its Bloemfontein Campus recently received a National Merit Award from the South African Institute of Architects (SAIA). The awards were announced at the 2021/2022 Corobrik SAIA Awards of Merit and Awards for Excellence ceremony in Johannesburg.

The multi-functional Modular Lecture Building, considered a hub for innovative learning, was designed by Roodt Architects in partnership with GXY Architects.

The adjudication panel received a total of 42 architectural projects from around the country, including infrastructure developments in the public and private sector. The SAIA Awards programme is structured over a two-year period and is conducted in two stages. In stage one regional awards for architecture are presented by the nine regional institutes affiliated to SAIA. In stage two the winning regional projects that are consequently entered into the national awards receive either a Commendation, an Award of Merit, and/or an Award for Excellence, which recognises exceptional achievement in the field of architecture.

In their citation the adjudicators noted that the Modular Lecture Building sets a benchmark for rational planning and technical efficiency and helps complete the campus urban framework through its placing and material choices.

Multi-functional spaces for students

Nico Janse van Rensburg, Senior Director at UFS University Estates, said the recognition is a testament to the UFS’s aspirations to renew, rejuvenate, regenerate, and revisit facilities and infrastructure.

“This award proves that excellence can be achieved with a reasonable set budget,” Janse van Rensburg said. “Energy efficiency and green building principles can be achieved by careful planning and teamwork.”

The Modular Lecture Building offers a variety of much-needed flexible teaching and learning spaces. “I have been using the facilities in this building for two years now, and I can say the building is much more spacious and conducive to studying,” said Hymne Spies, a third-year BSc student majoring in biochemistry and genetics. “The many plugs make it more efficient for studying, as one can plug in his or her laptop. There is also a nice computer lab for us to make use of.”

The UFS is proud that the construction of this facility forms part of a bigger endeavour – to create a cohesive campus identity that improves core business and to further extend its innovation and excellence as per its Vision 130.

Take a tour of the new Modular Lecturing Space and Assessment Centre Building:

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept